Literature DB >> 3391642

The role of antibody in immunity against experimental naegleria meningoencephalitis ('amoebic meningitis').

A Ferrante1, B Rowan-Kelly.   

Abstract

Mice immunized with amoeba culture fluid (ACF) from axenically cultured Naegleria fowleri showed marked protection against a lethal amoeba challenge, a result consistent with previous observations from this laboratory. The nature of this acquired resistance is not known. The data presented show that the degree of protection conferred to mice by immunization is related to the levels of antinaegleria antibodies. These antibodies react with the surface of the amoeba. The data also show that serum (and the IgG serum fraction) from immunized mice confer protection to normal mice against a lethal N. fowleri challenge. Spleen cells from immunized animals were only capable of conferring protection to recipients, when the challenge time was delayed (10 days), at which time anti-naegleria antibodies appeared in the serum of the mice. The studies suggest that antibodies play an important role in the ACF-induced resistance to experimental naegleria meningoencephalitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3391642      PMCID: PMC1384949     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Immunization of mice against Naegleria fowleri infection.

Authors:  D T John; R R Weik; A C Adams
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

Review 2.  Primary amoebic meningo-encephalitis. An appraisal of present knowledge.

Authors:  R F Carter
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

3.  Light and electron microsopic observations on the pathogenesis of Naegleria fowleri in mouse brain and tissue culture.

Authors:  G S Visvesvara; C S Callaway
Journal:  J Protozool       Date:  1974-05

4.  Experimental naegleria meningoencephalitis in mice. Penetration of the olfactory mucosal epithelium by Naegleria and pathologic changes produced: a light and electron microscope study.

Authors:  J Martinez; R J Duma; E C Nelson; F L Moretta
Journal:  Lab Invest       Date:  1973-08       Impact factor: 5.662

5.  The role of the spleen in protective immunity against Angiostrongylus cantonensis in rats: splenectomy and passive spleen cell transfers.

Authors:  W K Yong; R J Glanville; C Dobson
Journal:  Int J Parasitol       Date:  1983-04       Impact factor: 3.981

6.  Resistance of mice to Naegleria meningoencephalitis transferred by immune serum.

Authors:  Y H Thong; A Ferrante; C Shepherd; B Rowan-Kelly
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

7.  Description of a Naegleria sp. isolated from two cases of primary amoebic meningo-encephalitis, and of the experimental pathological changes induced by it.

Authors:  R F Carter
Journal:  J Pathol       Date:  1970-04       Impact factor: 7.996

8.  Protective immunity to Naegleria fowleri in experimental amebic meningoencephalitis.

Authors:  Y H Thong; C Shepherd; A Ferrante; B Rowan-Kelly
Journal:  Am J Trop Med Hyg       Date:  1978-03       Impact factor: 2.345

9.  Mitogenicity of Naegleria fowleri extract for murine T lymphocytes.

Authors:  A Ferrante; C Smyth
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

10.  Suppression of immunological responses in mice by treatment with amphotericin B.

Authors:  A Ferrante; B Rowan-Kelly; Y H Thong
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

View more
  2 in total

1.  Intranasal coadministration of the Cry1Ac protoxin with amoebal lysates increases protection against Naegleria fowleri meningoencephalitis.

Authors:  Saúl Rojas-Hernández; Marco A Rodríguez-Monroy; Rubén López-Revilla; Aldo A Reséndiz-Albor; Leticia Moreno-Fierros
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

2.  Augmentation of the neutrophil response to Naegleria fowleri by tumor necrosis factor alpha.

Authors:  A Ferrante
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.